ERBB3 overexpression is enriched in diverse patient populations with castration-sensitive prostate cancer and is associated with a unique AR activity signature
Article in Clinical Cancer Research (February 2024)
The most recent citing publications are shown below. View all 68 publications that cite this research output on Dimensions.
Article in Clinical Cancer Research (February 2024)
Book chapter (January 2024)
Article in Cell Reports (April 2023)